While almost all stocks in the cannabis and marijuana industry are traded on the OTC market, there is still speculative funds coming in from private investors, even if the price per share is in the pennies. Here is a quick overview of the performance of major marijuana industry pink sheet companies that are publicly traded. This particular firm uses a proprietary method to measure growth in the industry called the “420 Investor Stock Index,” which claims that year over year there has been an almost 7% increase in market growth. MarijuanaFeed.com and it’s affiliates do not provide any advice on investing in cannabis or any other business that is traded on the exchanges.
Cannabis stocks reignited after a brief pause yesterday and are up 26.4% in September. 55% of the 40 stocks tracked here rose in price, with 5 double-digit percentage gainers and 1 double-digit percentage loser. The percentage of stocks with volume above the 30-day average was 53%, up from 49% in the prior session, with two stocks trading over $5mm in value. Six of the ten highest dollar-volume stocks rose in price as five traded above $1mm. The 420 Investor Cannabis Stock Index increased from 41.40 to 41.92, reflecting a change of +6.8% year-to-date in 2016. The index began 2013 at 100, 2014 at 159.1, 2015 at 130.7, and 2016 at 39.25.
This table includes MQTRF and TWMJF, which are unsponsored ADRs, as well as dual-listed tickers ACBFF, APHQF, BLOZF, GWPH, OGRMF, SPRWF and THCBF and thus is not reflective of all the trading activity in those tickers.
Stocks moving more than 5% on more than $500k in volume included 22nd Century Group (XXII), Terra Tech (TRTC) and CV Sciences (CVSI) to the upside and none to the downside.